{"id":472132,"date":"2021-06-16T10:54:38","date_gmt":"2021-06-16T10:54:38","guid":{"rendered":"https:\/\/www.kapitalafrik.com\/?p=472132"},"modified":"2021-06-16T10:54:38","modified_gmt":"2021-06-16T10:54:38","slug":"covid-19-astrazeneca-treatment-flops","status":"publish","type":"post","link":"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/","title":{"rendered":"Covid-19: AstraZeneca treatment flops"},"content":{"rendered":"<div class=\"pdfprnt-buttons pdfprnt-buttons-post pdfprnt-top-bottom-left\"><\/div><p>Another setback for AstraZeneca. The Anglo-Swedish pharmaceutical group announced on Tuesday that the treatment against the coronavirus it is currently developing has not proven effective in people exposed to the virus.<\/p>\n<p>&#8220;The trial failed to achieve the primary goal of preventing symptomatic Covid-19 cases after exposure&#8221; to the virus, AstraZeneca said in a statement.<\/p>\n<p>Antibody therapy, codenamed AZD7442, was expected to both prevent and treat the disease. It was in phase 3 of development, that is, in large-scale clinical trials to measure its safety and effectiveness.<\/p>\n<p>The 1,121 participants were adults over the age of 18 who had not been vaccinated and who had been exposed to an infected person within the previous eight days. Treatment only reduced the risk of developing Covid-19 with symptoms by 33%. Trials are continuing to evaluate the remedy in patients before exposure to the virus, and in those who have developed severe forms.<\/p>\n<p>The development of this treatment is funded by the US government, which in turn had made agreements with AstraZeneca to receive up to 700,000 doses this year. In total, the value of the agreements with the United States for the development of the treatment and the doses in 2021 reaches 726 million dollars.<\/p>\n<div class=\"pdfprnt-buttons pdfprnt-buttons-post pdfprnt-top-bottom-left\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Another setback for AstraZeneca. The Anglo-Swedish pharmaceutical group announced on Tuesday that the treatment against the coronavirus it is currently developing has not proven effective in people exposed to the virus. &#8220;The trial failed to achieve the primary goal of preventing symptomatic Covid-19 cases after exposure&#8221; to the virus, AstraZeneca said in a statement. Antibody<\/p>\n","protected":false},"author":536282,"featured_media":472133,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"aside","meta":{"pmpro_default_level":"","jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"translated_post_url_fr":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[12591,12046],"tags":[18950,18952,16344,18951],"class_list":{"0":"post-472132","1":"post","2":"type-post","3":"status-publish","4":"format-aside","5":"has-post-thumbnail","7":"category-feature","8":"category-leaders-en","9":"tag-astrazeneca","10":"tag-astrazeneca-treatment","11":"tag-covid-19","12":"tag-treatment-flops","13":"post_format-post-format-aside","14":"pmpro-has-access"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.5 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Covid-19: AstraZeneca treatment flops - Financial Afrik<\/title>\n<meta name=\"description\" content=\"Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, givemeaning to statistics. Our \u201cexaggerated pretensions\u201d inspire us. We will strive, and gradually, to conceive, comfort and reach them. Three versions, three approaches and a global vision. The website is constantly on the news. The newsletter relays information every morning to executives, bankers, university financiers, students. The monthly edition analyzes the information and explains the setbacks. A single credo initiates our journalistic approach: information = actors, facts = a pluralistic vision. We aspire to neutrality, but we assume our subjectivity\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Covid-19: AstraZeneca treatment flops\" \/>\n<meta property=\"og:description\" content=\"Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, givemeaning to statistics. Our \u201cexaggerated pretensions\u201d inspire us. We will strive, and gradually, to conceive, comfort and reach them. Three versions, three approaches and a global vision. The website is constantly on the news. The newsletter relays information every morning to executives, bankers, university financiers, students. The monthly edition analyzes the information and explains the setbacks. A single credo initiates our journalistic approach: information = actors, facts = a pluralistic vision. We aspire to neutrality, but we assume our subjectivity\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/\" \/>\n<meta property=\"og:site_name\" content=\"Financial Afrik\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/FinancialAfrik\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-16T10:54:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2021\/06\/AstraZeneca.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"696\" \/>\n\t<meta property=\"og:image:height\" content=\"391\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Albert Savana\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Financialafrik\" \/>\n<meta name=\"twitter:site\" content=\"@Financialafrik\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Albert Savana\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2021\\\/06\\\/16\\\/covid-19-astrazeneca-treatment-flops\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2021\\\/06\\\/16\\\/covid-19-astrazeneca-treatment-flops\\\/\"},\"author\":{\"name\":\"Albert Savana\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#\\\/schema\\\/person\\\/12e2e10e56f65df0540cb842b7b0ce22\"},\"headline\":\"Covid-19: AstraZeneca treatment flops\",\"datePublished\":\"2021-06-16T10:54:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2021\\\/06\\\/16\\\/covid-19-astrazeneca-treatment-flops\\\/\"},\"wordCount\":199,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2021\\\/06\\\/16\\\/covid-19-astrazeneca-treatment-flops\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/AstraZeneca.jpeg\",\"keywords\":[\"AstraZeneca\",\"AstraZeneca treatment\",\"COVID-19\",\"treatment flops\"],\"articleSection\":[\"Featured\",\"Leaders\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2021\\\/06\\\/16\\\/covid-19-astrazeneca-treatment-flops\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2021\\\/06\\\/16\\\/covid-19-astrazeneca-treatment-flops\\\/\",\"url\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2021\\\/06\\\/16\\\/covid-19-astrazeneca-treatment-flops\\\/\",\"name\":\"Covid-19: AstraZeneca treatment flops - Financial Afrik\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2021\\\/06\\\/16\\\/covid-19-astrazeneca-treatment-flops\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2021\\\/06\\\/16\\\/covid-19-astrazeneca-treatment-flops\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/AstraZeneca.jpeg\",\"datePublished\":\"2021-06-16T10:54:38+00:00\",\"description\":\"Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, givemeaning to statistics. Our \u201cexaggerated pretensions\u201d inspire us. We will strive, and gradually, to conceive, comfort and reach them. Three versions, three approaches and a global vision. The website is constantly on the news. The newsletter relays information every morning to executives, bankers, university financiers, students. The monthly edition analyzes the information and explains the setbacks. A single credo initiates our journalistic approach: information = actors, facts = a pluralistic vision. We aspire to neutrality, but we assume our subjectivity\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2021\\\/06\\\/16\\\/covid-19-astrazeneca-treatment-flops\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/2021\\\/06\\\/16\\\/covid-19-astrazeneca-treatment-flops\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/AstraZeneca.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/AstraZeneca.jpeg\",\"width\":696,\"height\":391},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/\",\"name\":\"Kapital Afrik\",\"description\":\"All African finance\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#organization\",\"name\":\"Kapital Afrik | All African finance\",\"url\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.kapitalafrik.com\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/logo-430x76-kapital-afrik-.png\",\"contentUrl\":\"https:\\\/\\\/www.kapitalafrik.com\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/logo-430x76-kapital-afrik-.png\",\"width\":1740,\"height\":266,\"caption\":\"Kapital Afrik | All African finance\"},\"image\":{\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/FinancialAfrik\\\/\",\"https:\\\/\\\/x.com\\\/Financialafrik\",\"https:\\\/\\\/www.instagram.com\\\/financialafrikbusiness\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/financial-afrik\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCSeoXcgLHLSVaKqMP7cQaJQ\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/#\\\/schema\\\/person\\\/12e2e10e56f65df0540cb842b7b0ce22\",\"name\":\"Albert Savana\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/737f44bf39e476a47e7bb9a67e72167d5e85975b11fe69e8ecc2786be6ba9c2c?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/737f44bf39e476a47e7bb9a67e72167d5e85975b11fe69e8ecc2786be6ba9c2c?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/737f44bf39e476a47e7bb9a67e72167d5e85975b11fe69e8ecc2786be6ba9c2c?s=96&d=blank&r=g\",\"caption\":\"Albert Savana\"},\"url\":\"https:\\\/\\\/www.financialafrik.com\\\/en\\\/author\\\/albert-savana\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Covid-19: AstraZeneca treatment flops - Financial Afrik","description":"Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, givemeaning to statistics. Our \u201cexaggerated pretensions\u201d inspire us. We will strive, and gradually, to conceive, comfort and reach them. Three versions, three approaches and a global vision. The website is constantly on the news. The newsletter relays information every morning to executives, bankers, university financiers, students. The monthly edition analyzes the information and explains the setbacks. A single credo initiates our journalistic approach: information = actors, facts = a pluralistic vision. We aspire to neutrality, but we assume our subjectivity","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/","og_locale":"en_US","og_type":"article","og_title":"Covid-19: AstraZeneca treatment flops","og_description":"Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, givemeaning to statistics. Our \u201cexaggerated pretensions\u201d inspire us. We will strive, and gradually, to conceive, comfort and reach them. Three versions, three approaches and a global vision. The website is constantly on the news. The newsletter relays information every morning to executives, bankers, university financiers, students. The monthly edition analyzes the information and explains the setbacks. A single credo initiates our journalistic approach: information = actors, facts = a pluralistic vision. We aspire to neutrality, but we assume our subjectivity","og_url":"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/","og_site_name":"Financial Afrik","article_publisher":"https:\/\/www.facebook.com\/FinancialAfrik\/","article_published_time":"2021-06-16T10:54:38+00:00","og_image":[{"width":696,"height":391,"url":"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2021\/06\/AstraZeneca.jpeg","type":"image\/jpeg"}],"author":"Albert Savana","twitter_card":"summary_large_image","twitter_creator":"@Financialafrik","twitter_site":"@Financialafrik","twitter_misc":{"Written by":"Albert Savana","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/#article","isPartOf":{"@id":"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/"},"author":{"name":"Albert Savana","@id":"https:\/\/www.financialafrik.com\/en\/#\/schema\/person\/12e2e10e56f65df0540cb842b7b0ce22"},"headline":"Covid-19: AstraZeneca treatment flops","datePublished":"2021-06-16T10:54:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/"},"wordCount":199,"commentCount":0,"publisher":{"@id":"https:\/\/www.financialafrik.com\/en\/#organization"},"image":{"@id":"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/#primaryimage"},"thumbnailUrl":"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2021\/06\/AstraZeneca.jpeg","keywords":["AstraZeneca","AstraZeneca treatment","COVID-19","treatment flops"],"articleSection":["Featured","Leaders"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/","url":"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/","name":"Covid-19: AstraZeneca treatment flops - Financial Afrik","isPartOf":{"@id":"https:\/\/www.financialafrik.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/#primaryimage"},"image":{"@id":"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/#primaryimage"},"thumbnailUrl":"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2021\/06\/AstraZeneca.jpeg","datePublished":"2021-06-16T10:54:38+00:00","description":"Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, givemeaning to statistics. Our \u201cexaggerated pretensions\u201d inspire us. We will strive, and gradually, to conceive, comfort and reach them. Three versions, three approaches and a global vision. The website is constantly on the news. The newsletter relays information every morning to executives, bankers, university financiers, students. The monthly edition analyzes the information and explains the setbacks. A single credo initiates our journalistic approach: information = actors, facts = a pluralistic vision. We aspire to neutrality, but we assume our subjectivity","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.financialafrik.com\/en\/2021\/06\/16\/covid-19-astrazeneca-treatment-flops\/#primaryimage","url":"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2021\/06\/AstraZeneca.jpeg","contentUrl":"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2021\/06\/AstraZeneca.jpeg","width":696,"height":391},{"@type":"WebSite","@id":"https:\/\/www.financialafrik.com\/en\/#website","url":"https:\/\/www.financialafrik.com\/en\/","name":"Kapital Afrik","description":"All African finance","publisher":{"@id":"https:\/\/www.financialafrik.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.financialafrik.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.financialafrik.com\/en\/#organization","name":"Kapital Afrik | All African finance","url":"https:\/\/www.financialafrik.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.financialafrik.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.kapitalafrik.com\/wp-content\/uploads\/2020\/06\/logo-430x76-kapital-afrik-.png","contentUrl":"https:\/\/www.kapitalafrik.com\/wp-content\/uploads\/2020\/06\/logo-430x76-kapital-afrik-.png","width":1740,"height":266,"caption":"Kapital Afrik | All African finance"},"image":{"@id":"https:\/\/www.financialafrik.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/FinancialAfrik\/","https:\/\/x.com\/Financialafrik","https:\/\/www.instagram.com\/financialafrikbusiness\/","https:\/\/www.linkedin.com\/in\/financial-afrik\/","https:\/\/www.youtube.com\/channel\/UCSeoXcgLHLSVaKqMP7cQaJQ\/"]},{"@type":"Person","@id":"https:\/\/www.financialafrik.com\/en\/#\/schema\/person\/12e2e10e56f65df0540cb842b7b0ce22","name":"Albert Savana","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/737f44bf39e476a47e7bb9a67e72167d5e85975b11fe69e8ecc2786be6ba9c2c?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/737f44bf39e476a47e7bb9a67e72167d5e85975b11fe69e8ecc2786be6ba9c2c?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/737f44bf39e476a47e7bb9a67e72167d5e85975b11fe69e8ecc2786be6ba9c2c?s=96&d=blank&r=g","caption":"Albert Savana"},"url":"https:\/\/www.financialafrik.com\/en\/author\/albert-savana\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/www.financialafrik.com\/en\/wp-content\/uploads\/2021\/06\/AstraZeneca.jpeg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/posts\/472132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/users\/536282"}],"replies":[{"embeddable":true,"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/comments?post=472132"}],"version-history":[{"count":0,"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/posts\/472132\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/media\/472133"}],"wp:attachment":[{"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/media?parent=472132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/categories?post=472132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.financialafrik.com\/en\/wp-json\/wp\/v2\/tags?post=472132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}